alpha-galactosidase


Also found in: Wikipedia.

alpha-galactosidase

an enzyme that catalyzes the conversion of alpha-d-galactoside to d-galactose.
References in periodicals archive ?
Also included are drug profiles for (migalastat hydrochloride + agalsidase alfa), agalsidase alfa, agalsidase beta biosimilar, Alpha-Galactosidase, Genz-682452, GZ-402671, JR-051, migalastat hydrochloride, Next Generation biologics for Pompe, Fabry and Hunter, NP-003, PRX-102 and Recombinant Enzyme to Replace Alpha-Galactosidase A for Fabry's Disease.
Fabry disease (FD) is a disease characterized by the pathological accumulation of glycosphingolipid Gb3 in some cells; it progresses with a lack of lysosomal alpha-galactosidase and is inherited in an X-linked recessive manner (1).
Topics include: current market and expected developments; xylanases and cellulases as feed additives; mannanase, alpha-galactosidase and pectinase; phytases; effect of digestive tract conditions, feed processing, and ingredients on response to NSP enzymes; developments in enzyme use in ruminants; other relevant enzyme applications; analysis of enzymes, principles and problems, and the future of feed enzymes.
Additionally, Endofeed and Amylofeed contain side activities such as alpha-galactosidase, beta-mannanase, cellulases and hemicellulases.
REPLAGAL is a human form of enzyme alpha-galactosidase A (a-Gal A) manufactured in a human cell line by gene activation.
study published in the Journal of Allergy and Clinical Immunology, said that in susceptible people such as Newell, a tick bite that causes a significant skin reaction seems to trigger the production of an antibody that binds to a sugar present on meat called alpha-galactosidase, also known as alpha-gal.
from other members of the Enterobacteriaciae by their ability to produce alpha-galactosidase in the absence of beta-galactosidase, using a dual chromogen system for visualisation.
Fabry disease is a lysosomal storage disorder caused by inherited genetic mutations in the GLA gene, which result in deficient activity of the enzyme alpha-galactosidase A (alpha-GAL).
The action of coffee bean alpha-galactosidase on blood group B and BP1 substances.
Fabry Disease is caused by a deficiency of an enzyme, alpha-galactosidase A (also called ceramidetrihexosidase), involved in the breakdown of fats.
Alpha-galactosidase, aka Beano, reduces gas as it breaks down gas-producing sugars in beans and other vegetables.